Literature DB >> 17138029

High prevalence of clinically silent severe mitral regurgitation in patients with heart failure: role for echocardiography.

Padmini Varadarajan1, Sanjay Sharma, J Thomas Heywood, Ramdas G Pai.   

Abstract

Mitral regurgitation (MR) is common in patients with congestive heart failure (CHF) and has adverse effects on prognosis. In view of the altered hemodynamics in CHF, we examined the accuracy of auscultation for its detection in CHF with reduced systolic function. We examined 370 patients on stable heart failure therapy enrolled in our CHF clinic, if they had a physical examination by one of the two senior cardiologists and an echocardiogram within 2 weeks after the physical examination. The MR murmur was graded 0 to 6 on physical examination. MR was graded 0 to 4 on echocardiography using standard echocardiographic criteria. The left ventricular (LV) ejection fraction was 21 +/- 12% and age was 65 +/- 15 years. By echocardiography MR was present in 345 patients (94%), being 1+ in 162 (44%), 2+ in 80 (22%), 3+ in 54 (15%), and 4+ in 51 (14%). The frequency of an audible MR murmur by physical examination was 4% in 1+ MR, 11% in 2+ MR, 13% in 3+ MR, and 37% in 4+ MR. The audibility of MR murmur was not related to age, sex, body size, LV size, ejection fraction, or left atrial size. In conclusion, grade 3 or 4+ MR is present in one third of patients with CHF and reduced ejection fraction, and is inaudible in three quarters of them by physical examination. Echocardiography is needed for its detection. Audibility of MR murmur cannot be predicted by body size, LV size, or LV function in these patients.

Entities:  

Mesh:

Year:  2006        PMID: 17138029     DOI: 10.1016/j.echo.2006.06.009

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

Review 1.  A Short History of Cardiac Inspection: A Quest "To See with a Better Eye".

Authors:  William N Evans
Journal:  Pediatr Cardiol       Date:  2015-04-03       Impact factor: 1.655

Review 2.  Treatment of Functional Mitral Regurgitation in Heart Failure.

Authors:  Enrico Fabris; Antonio De Luca; Giancarlo Vitrella; Davide Stolfo; Marco Masè; Renata Korcova; Marco Merlo; Serena Rakar; Arnoud W J Van't Hof; Elvin Kedhi; Andrea Perkan; Gianfranco Sinagra
Journal:  Curr Cardiol Rep       Date:  2019-11-16       Impact factor: 2.931

3.  The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.

Authors:  Andrew J S Coats; Stefan D Anker; Andreas Baumbach; Ottavio Alfieri; Ralph Stephan von Bardeleben; Johann Bauersachs; Jeroen J Bax; Serge Boveda; Jelena Čelutkienė; John G Cleland; Nikolaos Dagres; Thomas Deneke; Dimitrios Farmakis; Gerasimos Filippatos; Jörg Hausleiter; Gerhard Hindricks; Ewa A Jankowska; Mitja Lainscak; Christoph Leclercq; Lars H Lund; Theresa McDonagh; Mandeep R Mehra; Marco Metra; Nathan Mewton; Christian Mueller; Wilfried Mullens; Claudio Muneretto; Jean-Francois Obadia; Piotr Ponikowski; Fabien Praz; Volker Rudolph; Frank Ruschitzka; Alec Vahanian; Stephan Windecker; Jose Luis Zamorano; Thor Edvardsen; Hein Heidbuchel; Petar M Seferovic; Bernard Prendergast
Journal:  Eur Heart J       Date:  2021-03-18       Impact factor: 29.983

4.  Secondary mitral regurgitation repair techniques and outcomes: Subannular repair techniques in secondary mitral regurgitation type IIIb.

Authors:  Jonas Pausch; Evaldas Girdauskas; Lenard Conradi; Hermann Reichenspurner
Journal:  JTCVS Tech       Date:  2021-09-16

5.  Early Outcomes of Endoscopic Papillary Muscle Relocation for Secondary Mitral Regurgitation Type IIIb in Patients With Severe Left Ventricular Dysfunction.

Authors:  Jonas Pausch; Oliver D Bhadra; Tatiana M Sequeira Gross; Xiaoqin Hua; Lenard Conradi; Hermann Reichenspurner; Evaldas Girdauskas
Journal:  Innovations (Phila)       Date:  2022-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.